Lv6
1770 积分 2021-04-29 加入
Finerenone: a next-generation nonsteroidal mineralocorticoid receptor antagonist reshaping the management of cardiovascular and metabolic diseases
9天前
已完结
Mineralocorticoid Receptor Blockers: Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonists
9天前
已完结
Predictors of Hyperkalemia Risk following Hypertension Control with Aldosterone Blockade
25天前
已关闭
Renal damage in primary aldosteronism
1个月前
已完结
Hypertrophic cardiomyopathy: changing the paradigm of exercise prescription and competitive sport participation
1个月前
已完结
Aldosterone and Treatment-Resistant Hypertension
1个月前
已完结
An analysis regarding the article “Artificial intelligence-enhanced electrocardiogram for the diagnosis of cardiac amyloidosis: A systemic review and meta-analysis”
3个月前
已完结
Effect of baxdrostat on ambulatory blood pressure in patients with resistant hypertension (Bax24): a phase 3, randomised, double-blind, placebo-controlled trial
3个月前
已完结
Diagnosis and management of resistant hypertension
3个月前
已完结
Effect of baxdrostat on ambulatory blood pressure in patients with resistant hypertension (Bax24): a phase 3, randomised, double-blind, placebo-controlled trial
4个月前
已完结
皖公网安备34019202002308
